On June 17, 2024, TG Therapeutics, Inc announced that it held its annual general meeting of shareholders on June 14, 2024, and declared voting results. Accordingly, the Company shareholders elected the board nominees: Laurence N. Charney, Yann Echelard, Kenneth Hoberman, Daniel Hume, Sagar Lonial, and Michael S. Weiss, to the Company board to hold office until the 2025 annual meeting.